Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Myers

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Biological Chemistry|May 7, 2003
Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptideLonnie Lybarger, Y Y Lawrence Yu, Michael J Miley, et al.
Journal for Immunotherapy of Cancer|April 13, 2026
Data-informed optimization of CAR T-cell therapy long-term follow-upBetsy Foss-Campbell, Nancy Myers, Rakesh Awasthi, et al.
Cancer Immunology Research|February 6, 2026
Neoadjuvant endocrine treatment plus mammaglobin-A DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of breast cancer patients: Insights from a phase 1b clinical trialRashmi Mishra, Foluso Ademuyiwa, Yilin Yang, et al.
Cancer Immunology Research|June 17, 2017
Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor ImmunityXiuli Zhang, Samuel Kim, Jasreet Hundal, et al.
Arxiv|December 19, 2025
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trialsKartik Singhal, Evelyn Schmidt, Susanna Kiwala, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Biological Chemistry|May 7, 2003
Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptideLonnie Lybarger, Y Y Lawrence Yu, Michael J Miley, et al.
Journal for Immunotherapy of Cancer|April 13, 2026
Data-informed optimization of CAR T-cell therapy long-term follow-upBetsy Foss-Campbell, Nancy Myers, Rakesh Awasthi, et al.
Cancer Immunology Research|February 6, 2026
Neoadjuvant endocrine treatment plus mammaglobin-A DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of breast cancer patients: Insights from a phase 1b clinical trialRashmi Mishra, Foluso Ademuyiwa, Yilin Yang, et al.
Cancer Immunology Research|June 17, 2017
Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor ImmunityXiuli Zhang, Samuel Kim, Jasreet Hundal, et al.
Arxiv|December 19, 2025
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trialsKartik Singhal, Evelyn Schmidt, Susanna Kiwala, et al.
Pageof 2